Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 224, Issue 4, Pages 586-594Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiab255
Keywords
memory B cell; memory T cell; neutralizing antibody; persistence; SARS-CoV-2
Categories
Funding
- Beijing Natural Science Foundation [L202038]
- Natural Science Foundation of China [81773494]
- National Key Research and Development Program of China [2019YFC1200502]
Ask authors/readers for more resources
This study investigated the humoral and T and B cell responses in COVID-19 patients up to 343 days after infection. It found that most patients still had virus-specific immune memory responses approximately 1 year post-infection, which is promising for prevention from reinfection and vaccination strategies.
Background. The duration of humoral and T and B cell response after the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unclear. Methods. We performed a cross-sectional study to assess the virus-specific antibody and memory T and B cell responses in coronavirus disease 2019 (COVID-19) patients up to 343 days after infection. Neutralizing antibodies and antibodies against the receptor-binding domain, spike, and nucleoprotein of SARS-CoV-2 were measured. Virus-specific memory T and B cell responses were analyzed. Results. We enrolled 59 patients with COVID-19, including 38 moderate, 16 mild, and 5 asymptomatic patients; 31 (52.5%) were men and 28 (47.5%) were women. The median age was 41 years (interquartile range, 30-55). The median day from symptom onset to enrollment was 317 days (range 257 to 343 days). We found that approximately 90% of patients still have detectable immunoglobulin (Ig)G antibodies against spike and nucleocapsid proteins and neutralizing antibodies against pseudovirus, whereas similar to 60% of patients had detectable IgG antibodies against receptor-binding domain and surrogate virus-neutralizing antibodies. The SARS-CoV-2-specific IgG(+) memory B cell and interferon-gamma-secreting T cell responses were detectable in more than 70% of patients. Conclusions. Severe acute respiratory syndrome coronavirus 2-specific immune memory response persists in most patients approximately 1 year after infection, which provides a promising sign for prevention from reinfection and vaccination strategy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available